Compare Stocks: RTTR and ETON

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ETON Eton Pharmaceuticals	$50.02 +1.5%	$57.10	$14.27 ▼ $66.37	$1.41B	0.9	609,676 shs	483,477 shs
RTTR Ritter Pharmaceuticals	$1.34 +8.1%	$2.99	$0.15 ▼ $1.27	$61.85M	-0.43	14.23 million shs	28,860 shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ETON Eton Pharmaceuticals	+1.46%	-2.55%	-12.38%	+17.45%	+168.06%
RTTR Ritter Pharmaceuticals	0.00%	0.00%	0.00%	0.00%	-64.92%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ETON Eton Pharmaceuticals	$50.02 +1.5%	$57.10	$14.27 ▼ $66.37	$1.41B	0.9	609,676 shs	483,477 shs
RTTR Ritter Pharmaceuticals	$1.34 +8.1%	$2.99	$0.15 ▼ $1.27	$61.85M	-0.43	14.23 million shs	28,860 shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ETON Eton Pharmaceuticals	+1.46%	-2.55%	-12.38%	+17.45%	+168.06%
RTTR Ritter Pharmaceuticals	0.00%	0.00%	0.00%	0.00%	-64.92%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ETON Eton Pharmaceuticals	3.00	Buy	$71.50	42.94% Upside
RTTR Ritter Pharmaceuticals	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest RTTR and ETON Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/15/2026	ETON Eton Pharmaceuticals	Craig Hallum Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$78.00
10/14/2026	ETON Eton Pharmaceuticals	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$70.00
10/12/2026	ETON Eton Pharmaceuticals	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold ➝ Strong-Buy
9/22/2026	ETON Eton Pharmaceuticals	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (D-) ➝ Hold (C)
8/24/2026	ETON Eton Pharmaceuticals	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Strong Sell ➝ Hold
8/14/2026	ETON Eton Pharmaceuticals	Canaccord Genuity Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$60.00 ➝ $68.00
8/14/2026	ETON Eton Pharmaceuticals	B. Riley Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$40.00 ➝ $70.00
8/14/2026	ETON Eton Pharmaceuticals	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$65.00 ➝ $70.00
8/11/2026	ETON Eton Pharmaceuticals	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$57.00 ➝ $65.00
7/28/2026	ETON Eton Pharmaceuticals	Craig Hallum Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$40.00 ➝ $62.00

(Data available from 10/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ETON Eton Pharmaceuticals	$79.95M	17.88	$0.01 per share	9,511.50	$0.98 per share	51.04
RTTR Ritter Pharmaceuticals	N/A	N/A	N/A	N/A	$0.10 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ETON Eton Pharmaceuticals	-$4.60M	$0.38	131.63	25.78	N/A	12.02%	40.13%	12.37%	11/5/2026 (Estimated)
RTTR Ritter Pharmaceuticals	-$10.13M	N/A	N/A	N/A	N/A	N/A	N/A	-162.05%	N/A

Latest RTTR and ETON Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
11/5/2026	Q3 2026	ETON Eton Pharmaceuticals	$0.3125	N/A	N/A	N/A	$41.99 million	N/A
8/13/2026	Q2 2026	ETON Eton Pharmaceuticals	$0.1898	$0.43	+$0.2402	$0.35	$27.11 million	$37.59 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ETON Eton Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
RTTR Ritter Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ETON Eton Pharmaceuticals	0.41	1.52	1.30
RTTR Ritter Pharmaceuticals	N/A	3.67	3.67

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ETON Eton Pharmaceuticals	27.86%
RTTR Ritter Pharmaceuticals	0.84%

Insider Ownership

Company	Insider Ownership
ETON Eton Pharmaceuticals	16.49%
RTTR Ritter Pharmaceuticals	15.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ETON Eton Pharmaceuticals	44	28.58 million	23.87 million	Optionable
RTTR Ritter Pharmaceuticals	7	46.15 million	N/A	Not Optionable

RTTR and ETON Headlines

Recent News About These Companies

Rochester football bows to St. Louis Cardinal Ritter in battle of state champions

October 4, 2024 | sj-r.comS

Scott Ritter claims search of home is related to 'foreign agent’ law

August 9, 2024 | timesunion.comT

FBI raids NY home of ex-UN weapons inspector Scott Ritter

August 9, 2024 | nypost.comN

John Ritter Biography & Movies

May 22, 2024 | tribute.caT

Dr. John D. Ritter

January 23, 2024 | health.usnews.com

German chocolate war ends with Ritter Sport victory

October 28, 2023 | politico.euP

Kristen Ritter

September 15, 2023 | health.usnews.com

Op-ed column: Sandusky sex charges contrast with setup against Scott Ritter

July 8, 2023 | dailygazette.comD

Scott Ritter arrested in Pennsylvania on child sex charges

July 8, 2023 | dailygazette.comD

Dr. Harold K. Ritter

July 8, 2023 | health.usnews.com

Denver Business Journal welcomes new tech reporter

July 1, 2023 | bizjournals.com

Gary W. Ritter, Ph.D.

June 16, 2023 | slu.eduS

Jason Ritter and Drew Barrymore's raw conversation on her show may matter more than you think

April 10, 2023 | usatoday.com

Ritter Pharmaceuticals Changing the Game With Lactose Intolerance Treatment

March 29, 2023 | thestreet.com

Global Microbiome Market Report 2023: Major Players Include MicroBiome Therapeutics, Seres Therapeutics, Enterome Bioscience and Second Genome

March 18, 2023 | finance.yahoo.com

Melanie Lynskey's husband Jason Ritter will join her in Yellowjackets this season

January 19, 2023 | yahoo.com

Ritter Public Library in Vermilion adds book club

January 15, 2023 | morningjournal.comM

Microbiome Clinical Trial Pipeline Space Brims with Novel Emerging Therapies with 130+ Key Players Working in the Domain | DelveInsight

November 16, 2022 | finance.yahoo.com

Burlington freshman Olivia Ritter hits to pool as Olivia Kraus climbs out of the water

October 1, 2022 | thehawkeye.comT

Tuesday roundup: Sandy Valley senior golfer Connor Ritter records hole-in-one and sets new school record

September 11, 2022 | cantonrep.comC

New MarketBeat Followers Over Time

Media Sentiment Over Time

RTTR and ETON Company Descriptions

Eton Pharmaceuticals NASDAQ:ETON

$50.02 +0.72 (+1.46%)

Closing price 10/22/2026 04:00 PM Eastern

Extended Trading

$50.08 +0.05 (+0.11%)

As of 10/22/2026 07:30 PM Eastern

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Ritter Pharmaceuticals NASDAQ:RTTR

Ritter Pharmaceuticals, Inc. develops and sells novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which has completed Phase 2b clinical trial for the reduction of symptoms associated with lactose intolerance. The company's product, RP-G28 is designed to stimulate the growth of lactose-metabolizing bacteria in the colon, thereby adapting the gut microbiome to assist in digesting the lactose that reaches the large intestine. The company was formerly known as Ritter Natural Sciences, LLC and changed its name to Ritter Pharmaceuticals, Inc. in September 2008. Ritter Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Los Angeles, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest RTTR and ETON Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest RTTR and ETON Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

RTTR and ETON Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

RTTR and ETON Company Descriptions

Eton Pharmaceuticals NASDAQ:ETON

Ritter Pharmaceuticals NASDAQ:RTTR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest RTTR and ETON Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest RTTR and ETON Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

RTTR and ETON Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

RTTR and ETON Company Descriptions

Eton Pharmaceuticals NASDAQ:ETON

Ritter Pharmaceuticals NASDAQ:RTTR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools